Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Respiratory Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT05387278
What this trial is testing

Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeRespiratory Distress Syndrome
Vitti Labs, LLC 20
Not applicableActive Not RecruitingNCT05467917
What this trial is testing

ARMOR-Household: Characterizing Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases

Who this might be right for
COVID-19HouseholdsSARS CoV 2 Infection
Columbia University 374
Not applicableEnrolling By InvitationNCT07191080
What this trial is testing

Next-generation Sequencing Technology in the Clinical Application of Respiratory Specimens

Who this might be right for
Lung Infection
Bin Zhang 80
Large-scale testing (Phase 3)Ended earlyNCT04695704
What this trial is testing

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:

Who this might be right for
Covid19SARS (Disease)
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 86
Large-scale testing (Phase 3)Study completedNCT04494984
What this trial is testing

Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Who this might be right for
COVID-19
Inmunova S.A. 243
Not applicableLooking for participantsNCT06114784
What this trial is testing

Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study

Who this might be right for
Severe Pneumonia
First Affiliated Hospital of Zhejiang University 2,000
Not applicableLooking for participantsNCT04582903
What this trial is testing

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

Who this might be right for
COVID-19 Infection
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Large-scale testing (Phase 3)Study completedNCT04467840
What this trial is testing

Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia

Who this might be right for
COVID-19Lung Infection
RedHill Biopharma Limited 475
Post-approval studies (Phase 4)UnknownNCT02552342
What this trial is testing

Corticosteroid Therapy for Severe Community-Acquired Pneumonia

Who this might be right for
Community Acquired Pneumonia
Peking Union Medical College Hospital 610
Testing effectiveness (Phase 2)Study completedNCT01273766
What this trial is testing

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+133 more
Wake Forest University Health Sciences 16
Not applicableStudy completedNCT02016690
What this trial is testing

Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie 312
Not applicableStudy completedNCT04610554
What this trial is testing

Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19

Who this might be right for
COVID-19 Pneumonia
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 74
Large-scale testing (Phase 3)Study completedNCT04397562
What this trial is testing

A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19

Who this might be right for
COVID-19
Biocad 206
Large-scale testing (Phase 3)Study completedNCT00891462
What this trial is testing

Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 561
Large-scale testing (Phase 3)WithdrawnNCT04575064
What this trial is testing

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Who this might be right for
SARS-CoV-2 InfectionCOVID-19Moderate and Severe COVID-19
Professor Dr. Bernd Mühlbauer
Testing effectiveness (Phase 2)UnknownNCT04299152
What this trial is testing

Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome (SARS) Pneumonia
Throne Biotechnologies Inc. 20
Not applicableUnknownNCT04955756
What this trial is testing

Early Identification and Severity Prediction of Acute Respiratory Infectious Disease

Who this might be right for
Acute Respiratory InfectionSevere PneumoniaNext Generation Sequencing+1 more
Huashan Hospital 440
Large-scale testing (Phase 3)Study completedNCT04304053
What this trial is testing

Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention

Who this might be right for
COVID-19
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 2,300
Not applicableStudy completedNCT04490200
What this trial is testing

Effectiveness of a Novel Respirator With Chitosan Nanoparticles

Who this might be right for
Covid19SARS-CoV InfectionWorker-Patient Transmission, Healthcare
University of Brasilia 300
Testing effectiveness (Phase 2)Study completedNCT04710199
What this trial is testing

Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Virus Diseases
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 44
Next Page